The World Bank lowered its China growth forecast for the year from 4.3 percent predicted in June to 2.7 percent due to the impact of the pandemic and property sector weaknesses on its economy.
The institution also slashed its forecast for next year from 8.1 percent down to 4.3 percent.
Many analysts believe that China's GDP growth target of around 5.5 percent for the year is now unattainable.
According to the World Bank, outbreaks and growth slowdowns in China have been followed by uneven recoveries.
Disruption to businesses has continued in China as cases surge and some restrictions remain in place.
Health officials have acknowledged that since bulk testing criteria were removed, official data no longer accurately reflect domestic infections.
The IMF forewarned last week that it will likely also reduce its predictions for China, blaming a sustained rise in cases.
The fund revised its growth forecast for China in October, lowering it to 3.2 percent this year, the lowest level in decades from the 4.4 percent it expected the previous year.
According to IMF chief Kristalina Georgieva, they are very likely to downgrade the growth projections for China, both for 2022 and 2023,
As China moves forward with the reopening, experts worry that it is ill-prepared to handle the next wave of diseases since millions of susceptible elderly people have not yet had all of the recommended vaccinations.


Bill Ackman’s Pershing Square Returns to Netflix With Major New Stake
European Stocks Steady as U.S.-Iran War, Euro Zone Data Keep Investors Cautious
UK Economy Posts Surprise June Growth as World Cup and Hot Weather Lift Activity
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
LG, Nvidia Expand AI Partnership With Humanoid Robots, AI Factories
Alphabet’s SpaceX Investment Soars 100-Fold to $94 Billion
US Stock Futures Steady as Cooling Inflation and Strong Earnings Support Markets
US Dollar Slips as Weak Retail Sales Reduce Fed Rate Hike Bets
Oil Prices Fall as U.S. Crude Inventories Surge and Hormuz Tensions Persist
Synlait Milk Denies Fonterra, a2 Milk Takeover Talks
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth
Trump Signs Order to Cut Routine Childhood Vaccines
Ford to Move Some Lincoln Production From China to U.S. in 2030
S&P 500 Hits Record High as Soft Inflation Data Eases Fed Rate Hike Fears
J.P. Morgan Upgrades SanDisk, Sets $2,250 Price Target on AI NAND Growth
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 



